Dr. Tan Min-Han, founder and CEO of Lucence, joins the podcast to discuss the importance of precision health in Singapore and the region. He shares his journey from being a medical oncologist and researcher to becoming an entrepreneur focused on noninvasive early detection of cancer through liquid biopsies. In this episode, he emphasizes the urgent need for early cancer detection, as 80% of cancer deaths are from unscreened cancers. Listen as he highlights the challenges of implementing change in healthcare systems and the importance of engaging stakeholders to address these gaps. Finally, he also discusses Lucence's expansion to the United States and China, as well as the company's mission to bridge the gap in cancer detection worldwide. The show notes and transcripts for the episode can be found on nucleatesingapore.substack.com. For feedback or recommendations on who we should talk to next, please reach out to Joson Ng via [email protected].